AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 231 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,414,752 | -10.1% | 344,229 | +6.8% | 0.00% | 0.0% |
Q1 2024 | $3,797,389 | -21.4% | 322,359 | -5.3% | 0.00% | -50.0% |
Q4 2023 | $4,829,552 | +17.7% | 340,349 | +0.9% | 0.00% | 0.0% |
Q3 2023 | $4,102,164 | -3.2% | 337,349 | -0.0% | 0.00% | 0.0% |
Q2 2023 | $4,237,480 | +20.9% | 337,379 | +6.8% | 0.00% | 0.0% |
Q1 2023 | $3,503,985 | -9.2% | 315,959 | +0.0% | 0.00% | 0.0% |
Q4 2022 | $3,857,493 | +17.4% | 315,929 | +0.4% | 0.00% | 0.0% |
Q3 2022 | $3,286,000 | -58.4% | 314,729 | -57.3% | 0.00% | -50.0% |
Q2 2022 | $7,907,000 | +22.5% | 736,265 | +8.0% | 0.00% | +100.0% |
Q1 2022 | $6,457,000 | -22.5% | 681,845 | -5.5% | 0.00% | -33.3% |
Q4 2021 | $8,330,000 | +18.1% | 721,225 | -2.4% | 0.00% | 0.0% |
Q3 2021 | $7,054,000 | +92.9% | 738,648 | +94.7% | 0.00% | +200.0% |
Q2 2021 | $3,657,000 | -3.4% | 379,400 | -1.0% | 0.00% | -50.0% |
Q1 2021 | $3,785,000 | -68.7% | 383,100 | -26.9% | 0.00% | -66.7% |
Q4 2020 | $12,108,000 | +63.5% | 524,366 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $7,404,000 | -16.0% | 524,366 | -10.3% | 0.00% | -20.0% |
Q2 2020 | $8,819,000 | +166.6% | 584,836 | +63.3% | 0.01% | +150.0% |
Q1 2020 | $3,308,000 | -36.1% | 358,036 | -32.6% | 0.00% | -33.3% |
Q4 2019 | $5,177,000 | +101.7% | 531,503 | +66.0% | 0.00% | +50.0% |
Q3 2019 | $2,567,000 | -35.7% | 320,136 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $3,995,000 | +9.3% | 320,136 | +19.1% | 0.00% | 0.0% |
Q1 2019 | $3,656,000 | -25.9% | 268,836 | -47.8% | 0.00% | -50.0% |
Q4 2018 | $4,932,000 | +53.2% | 514,836 | +93.3% | 0.00% | +100.0% |
Q3 2018 | $3,220,000 | -22.6% | 266,336 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $4,160,000 | +25.6% | 266,336 | +21.0% | 0.00% | +50.0% |
Q1 2018 | $3,311,000 | -10.4% | 220,136 | -14.3% | 0.00% | -33.3% |
Q4 2017 | $3,696,000 | -27.4% | 256,846 | -24.0% | 0.00% | -25.0% |
Q3 2017 | $5,094,000 | +145.7% | 337,826 | +64.1% | 0.00% | +100.0% |
Q2 2017 | $2,073,000 | +64.3% | 205,836 | +16.3% | 0.00% | +100.0% |
Q1 2017 | $1,262,000 | -85.9% | 177,036 | -90.2% | 0.00% | -85.7% |
Q4 2016 | $8,967,000 | -34.3% | 1,804,222 | -2.2% | 0.01% | -41.7% |
Q3 2016 | $13,650,000 | +18.9% | 1,844,529 | -12.3% | 0.01% | +20.0% |
Q2 2016 | $11,478,000 | -23.6% | 2,102,242 | +18.2% | 0.01% | -23.1% |
Q1 2016 | $15,025,000 | -29.4% | 1,778,151 | -18.9% | 0.01% | -27.8% |
Q4 2015 | $21,272,000 | -23.2% | 2,192,974 | +10.8% | 0.02% | -25.0% |
Q3 2015 | $27,701,000 | +1140.5% | 1,980,077 | +1154.8% | 0.02% | +1100.0% |
Q2 2015 | $2,233,000 | +5482.5% | 157,800 | +4164.9% | 0.00% | – |
Q1 2015 | $40,000 | +29.0% | 3,700 | 0.0% | 0.00% | – |
Q4 2014 | $31,000 | -81.0% | 3,700 | -95.3% | 0.00% | – |
Q1 2014 | $163,000 | -15.5% | 78,565 | -4.5% | 0.00% | – |
Q4 2013 | $193,000 | -13.1% | 82,265 | -14.0% | 0.00% | – |
Q3 2013 | $222,000 | -1.8% | 95,665 | -1.6% | 0.00% | – |
Q2 2013 | $226,000 | – | 97,191 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 1,315,395 | $30,372,000 | 10.86% |
Palo Alto Investors LP | 7,867,114 | $181,652,000 | 9.52% |
Perceptive Advisors | 25,112,048 | $579,837,000 | 6.22% |
Redmile Group, LLC | 20,620,490 | $476,127,000 | 5.76% |
Avoro Capital Advisors LLC | 9,000,000 | $207,810,000 | 3.58% |
Ghost Tree Capital, LLC | 600,000 | $13,854,000 | 3.09% |
SECTORAL ASSET MANAGEMENT INC | 1,534,604 | $35,434,000 | 2.50% |
CM Management, LLC | 90,000 | $2,078,000 | 1.93% |
Boxer Capital, LLC | 2,325,000 | $53,684,000 | 1.73% |
Hood River Capital Management LLC | 2,204,140 | $50,894,000 | 1.68% |